-
1.
Epstein JB, Wong FL, Millner A, Le ND. Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial. Head Neck. 1994;16(6):539-44. [PubMed: 7529754].
-
2.
Ribeiro AS, Salles PR, da Silva TA, Mesquita RA. A review of the nonsurgical treatment of oral leukoplakia. Int J Dent. 2010;2010:186018. doi: 10.1155/2010/186018. [PubMed: 20339486].
-
3.
Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg. 2001;30(1):49-53. [PubMed: 11289621].
-
4.
Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006;(4). CD001829. doi: 10.1002/14651858.CD001829.pub3. [PubMed: 17054142].
-
5.
Lele S. Although leukoplakia responds to some treatments relapses and adverse effects are common. Evid Based Dent. 2005;6(1):15-6. doi: 10.1038/sj.ebd.6400311. [PubMed: 15789045].
-
6.
de Vries N, van Zandwijk N, Pastorino U. Chemoprevention of head and neck and lung (pre)cancer. Recent Results Cancer Res. 1999;151:13-25. [PubMed: 10337716].
-
7.
Malmstrom M, Hietanen J, Sane J, Sysmalainen M. Topical treatment of oral leukoplakia with bleomycin. Br J Oral Maxillofac Surg. 1988;26(6):491-8. [PubMed: 2462447].
-
8.
Hammersley N, Ferguson MM, Rennie JS. Topical bleomycin in the treatment of oral leukoplakia: a pilot study. Br J Oral Maxillofac Surg. 1985;23(4):251-8. [PubMed: 2412577].
-
9.
Hisano Y, Satoh T, Suzuki M, Kanai Y. [An effective case of local injection therapy of oral leukoplakia with bleomycin (author's transl)]. Shigaku. 1978;66(1):125-8. [PubMed: 94664].
-
10.
Hayasaki K, Kitamura T, Kaneko T, Tachibana M, Kobayashi N, Tosaka K, et al. [Application of BLM-iontophoresis for the tumor-therapy of the head and neck area (author's transl)]. Nihon Gan Chiryo Gakkai Shi. 1977;12(4):522-7. [PubMed: 75935].
-
11.
Galm U, Hager MH, Van Lanen SG, Ju J, Thorson JS, Shen B. Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chem Rev. 2005;105(2):739-58. doi: 10.1021/cr030117g. [PubMed: 15700963].
-
12.
Soni P, Khandelwal K, Aara N, Ghiya BC, Mehta RD, Bumb RA. Efficacy of Intralesional Bleomycin in Palmo-plantar and Periungual Warts. J Cutan Aesthet Surg. 2011;4(3):188-91. doi: 10.4103/0974-2077.91250. [PubMed: 22279384].
-
13.
Saitta P, Krishnamurthy K, Brown LH. Bleomycin in dermatology: a review of intralesional applications. Dermatol Surg. 2008;34(10):1299-313.
-
14.
Dhar SB, Rashid MM, Islam A, Bhuiyan M. Intralesional bleomycin in the treatment of cutaneous warts: a randomized clinical trial comparing it with cryotherapy. Indian J Dermatol Venereol Leprol. 2009;75(3):262-7. doi: 10.4103/0378-6323.48428. [PubMed: 19439878].
-
15.
Aziz-Jalali MH, Ghafarpour G, Rezaei MR, Behzadi AH, Nasab MR, Nilforoushzadeh MA. Efficacy of intralesional bleomycin in the treatment of resistant warts. J Skin Stem Cell. 2014;1(1):1887.
-
16.
Canellos GP, Duggan D, Johnson J, Niedzwiecki D. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?. J Clin Oncol. 2004;22(8):1532-3. doi: 10.1200/JCO.2004.99.010. [PubMed: 15084636].
-
17.
Bayer RA, Gaynor ER, Fisher RI. Bleomycin in non-Hodgkin's lymphoma. Semin Oncol. 1992;19(2 Suppl 5):46-52. discussion 52-3. [PubMed: 1384144].
-
18.
Kawai K, Akaza H. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer. Expert Opin Drug Saf. 2003;2(6):587-96. [PubMed: 14585067].
-
19.
Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevreau C, Kerbrat P, et al. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2008;18(3):446-52. [PubMed: 18494093].
-
20.
Tobias J, Buxton EJ, Blackledge G, Mould JJ, Monaghan J, Spooner D, et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother Pharmacol. 1990;26 Suppl:S59-62. [PubMed: 1693316].
-
21.
Kayalvizhi EB, Lakshman VL, Sitra G, Yoga S, Kanmani YR, Megalai N. Oral leukoplakia: A review and its update. J Med Radiol Pathol Surg. 2016;2:18-22.
-
22.
Tashiro H, Ozeki S, Higuchi Y, Okamoto M. Late occurring recurrence of oral cancer after combined treatment with bleomycin and radiotherapy. Cancer. 1988;61(12):2418-22. [PubMed: 2452683].
-
23.
Wong F, Epstein J, Millner A. Treatment of oral leukoplakia with topical bleomycin. A pilot study. Cancer. 1989;64(2):361-5. [PubMed: 2472197].
-
24.
Epstein JB, Gorsky M, Wong FL, Millner A. Topical bleomycin for the treatment of dysplastic oral leukoplakia. Cancer. 1998;83(4):629-34. [PubMed: 9708924].
-
25.
Tsuji T. Bleomycin iontophoretic therapy for verrucous carcinoma. Arch Dermatol. 1991;127(7):973-5. [PubMed: 1712184].
-
26.
Kapstad B, Bang G. Verrucous carcinoma of the oral cavity treated with bleomycin. Oral Surg Oral Med Oral Pathol. 1976;42(5):588-90. [PubMed: 62332].
-
27.
Strojan P, Soba E, Budihna M, Auersperg M. Radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin in the treatment of verrucous carcinoma of the head and neck. J Surg Oncol. 2005;92(4):278-83. doi: 10.1002/jso.20422. [PubMed: 16299796].
-
28.
Patil N, Paulose RM, Udupa KS, Ramakrishna N, Ahmed T. Pulmonary Toxicity of Bleomycin - A Case Series from a Tertiary Care Center in Southern India. J Clin Diagn Res. 2016;10(4):FR01-3. doi: 10.7860/JCDR/2016/18773.7626. [PubMed: 27190828].
-
29.
Carnevale-Schianca F, Gallo S, Rota-Scalabrini D, Sangiolo D, Fizzotti M, Caravelli D, et al. Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity?. J Clin Oncol. 2011;29(24):691-3. doi: 10.1200/JCO.2011.35.6733. [PubMed: 21709191].
-
30.
Debnath J, Singh HP, George RA, Satija L, Chawla N, Sarma YS, et al. Reversible Bleomycin Toxicity. Med J Armed Forces India. 2010;66(3):290-1. doi: 10.1016/S0377-1237(10)80071-1. [PubMed: 27408324].
-
31.
Keijzer A, Kuenen B. Fatal pulmonary toxicity in testis cancer with bleomycin-containing chemotherapy. J Clin Oncol. 2007;25(23):3543-4. doi: 10.1200/JCO.2007.12.2218. [PubMed: 17687159].
-
32.
Maher J, Daly PA. Severe bleomycin lung toxicity: reversal with high dose corticosteroids. Thorax. 1993;48(1):92-4. [PubMed: 7679525].
LEAVE A COMMENT HERE: